<DOC>
	<DOCNO>NCT01080638</DOCNO>
	<brief_summary>Intracoronary bolus Abciximab single non-inferior intravenous continuous 12- hour infusion size reduction infarction cardiac magnetic resonance Non-ST elevation Myocardial infarction .</brief_summary>
	<brief_title>Intracoronary Bolus Only Compared With Intravenous Bolus 12-hours Infusion Abciximab Non-ST Elevation Myocardial Infarction .</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Abciximab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin Fab Fragments</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>nonST segment elevation acute myocardial infarction within 48 hour presence chest pain TroponinT I positive CAG First myocardial infarction perform coronary angioplasty 18 year age,80 year older Bleeding tendency History major surgery within 4 week Major stroke within 2 year Thrombocytopenia ( &lt; 120,000 / uL ) Cardiogenic shock Known allergy aspirin , heparin , abciximab Contraindication MRI study entry ( implanted pacemaker , defibrillator , intracranial metallic implant etc ) Chronic atrial fibrillation Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>abciximab</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>angioplasty</keyword>
	<keyword>Platelet</keyword>
</DOC>